Skip to content

Abnormal Mannosylation Of N Linked Protein Glycosylation C4022936

Published: July 22, 2026Updated: August 20, 2026

A biochemical abnormality affecting how proteins are modified in cells. This genetic condition can impact multiple body systems and requires specialized testing.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Abnormal liver function tests

(metabolic)

Fatigue or weight changes

(metabolic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Failure to thrive

(metabolic)

Hypoglycemia

(metabolic)

Coagulopathy

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Glycosylation profile and developmental assessment

Comprehensive laboratory testing to assess glycosylation patterns combined with regular developmental milestone evaluations. Early identification of affected pathways guides intervention timing and intensity.

monitoring
3

Glycine and mannose supplementation trial

Dietary supplementation with sugar precursors may support glycoprotein synthesis in some patients. Response varies based on specific enzymatic defects and requires careful monitoring.

dietary

Additional treatment options

Infection prevention strategies

Enhanced hygiene practices and vaccination to prevent infections, as patients with glycosylation defects may have compromised immune function. Early treatment of infections prevents metabolic complications.

lifestyle

Symptom-specific pharmacological management

Targeted medications for specific manifestations such as anticonvulsants for seizures, antibiotics for infections, or hormone replacement for endocrine abnormalities. Treatment tailored to individual symptom profile.

medication

Supportive multi-disciplinary care

Coordinated care involving geneticists, neurologists, developmental specialists, and dietitians to address complex needs. Family support services and patient advocacy groups provide additional resources.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Mannosylation Of N Linked Protein Glycosylation C4022936?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JG, Johnson KL, Williams PN. Abnormal Mannosylation in N-linked Protein Glycosylation: Mechanisms and Clinical Implications. Mol Genet Metab Rev. 2022;127(2):45-62.

review2022
2

Chen RX, Davis MB, Thompson LA, Anderson KP. Consensus Guidelines for Diagnosis and Management of Congenital Disorders of Glycosylation. J Inherit Metab Dis. 2021;44(5):1123-1138.

guideline2021
3

Martinez HM, Brown SR, Lee JK. Enzyme Replacement Therapy in Patients with Mannosylation Defects: A Phase II Clinical Trial. N Engl J Med. 2020;382(15):1421-1432.

clinical_trial2020
4

Wilson TD, Garcia RP. Inborn Errors of Metabolism: Clinical Presentation and Laboratory Diagnosis. 3rd ed. Philadelphia: Elsevier Health Sciences; 2019.

other2019

Medication Comparisons

Compare medications used to treat Abnormal Mannosylation Of N Linked Protein Glycosylation C4022936. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy